Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy

Wei WANG; Lijuan LIU; Zhuo YANG; Chuanjian LU; Pengfei TU; Ruizhi ZHAO; Kewu ZENG

doi:10.1016/S1875-5364(24)60563-7

Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (2) :127 -136. DOI: 10.1016/S1875-5364(24)60563-7

Original article

research-article

Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy

Author information +

History +

PDF (1729KB)

Abstract

Psoriasis, a prevalent inherited skin condition, involves an inflammatory response as a key pathogenic mechanism. The Optimized Yinxieling Formula (OYF), rooted in traditional Chinese medicine, is extensively utilized in clinical settings to treat psoriasis. Although previous studies have demonstrated OYF’s significant anti-inflammatory effects in psoriasis, its potential molecular targets and active components remain unexplored. This study aimed to unveil the anti-psoriasis molecular targets and active components of OYF. Our findings indicated that OYF extract markedly reduced the production of several inflammatory mediators, including IL-23, nitric oxide, TNF-α, and IL-1β, in LPS-induced RAW264.7 cells. We synthesized OYF extract-crosslinked beads to isolate pharmacological targets from RAW264.7 lysates using an affinity purification strategy, known as Target Fishing. The enriched target proteins were subsequently identified via LC-MS/MS, followed by bioinformatics analysis to map the psoriasis-associated pathway-gene network. We identified a total of 76 potential target proteins, which were highly associated with mRNA transcription mechanisms. In particular, pathway-gene network analysis revealed that the IL-23 inflammatory pathway was involved in the anti-psoriasis effect of OYF extract. We further utilized a target protein-based affinity capture strategy, combined with LC-MS and SPR analysis, to globally screen OYF’s active components, focusing on the mRNA transcription regulator, fused in sarcoma (FUS). This process led to the identification of umbelliferone, vanillic acid, protocatechuic acid, gentisic acid, and echinacoside as key compounds targeting FUS to inhibit IL-23 expression. Additionally, we formulated a compound cocktail (CpdC), which significantly reduced psoriasis area and severity index (PASI) scores and the expressions of IL-23 and Ki67 in an imiquimod (IMQ)-induced psoriasis mouse model. Collectively, our study elucidates the primary molecular targets and active components of OYF, offering novel insights for psoriasis treatment.

Keywords

Psoriasis / Optimized Yinxieling Formula (OYF) / FUS protein / Molecular targets / Affinity-purified strategy.

Cite this article

Download citation ▾

Wei WANG, Lijuan LIU, Zhuo YANG, Chuanjian LU, Pengfei TU, Ruizhi ZHAO, Kewu ZENG. Anti-psoriasis molecular targets and active components discovery of Optimized Yinxieling Formula via affinity-purified strategy. Chinese Journal of Natural Medicines, 2024, 22(2): 127-136 DOI:10.1016/S1875-5364(24)60563-7

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Chiricozzi A, Romanelli P, Volpe E, et al. Scanning the immunopathogenesis of psoriasis[J]. Int J Mol Sci, 2018, 19(1): 179.

[2]	Tang YZ, Yu JY, Zhao W, et al. Total glucosides of Rhizoma Smilacis Glabrae: a therapeutic approach for psoriasis by regulating Th17/Treg balance[J]. Chin J Nat Med, 2023, 21(8): 589-598.

[3]	Rendon A, Schäkel K. Psoriasis pathogenesis and treatment[J]. Int J Mol Sci, 2019, 20(6): 1475.

[4]	Schäkel K, Schön MP, Ghoreschi K. Pathogenesis of psoriasis[J]. Hautarzt, 2016, 67(6): 422-431.

[5]	Reid C, Griffiths CEM. Psoriasis and treatment: past, present and future aspects[J]. Acta Derm Venereol, 2020, 100(3): adv00032.

[6]	Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis[J]. Can Fam Physician, 2017, 63(4): 278-285.

[7]	Wang Y, Edelmayer R, Wetter J, et al. Monocytes/macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation[J]. Sci Rep, 2019, 9(1): 5310.

[8]	Hou Y, Zhu L, Tian H, et al. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis[J]. Protein Cell, 2018, 9(12): 1027-1038.

[9]	Girolomoni G, Strohal R, Puig L, et al. The role of IL-23 and the IL-23/T_H 17 immune axis in the pathogenesis and treatment of psoriasis[J]. J Eur Acad Dermatol Venereol, 2017, 31(10): 1616-1626.

[10]	Vičić M, Kaštelan M, Brajac I, et al. Current concepts of psoriasis immunopathogenesis[J]. Int J Mol Sci, 2021, 22(21): 11574.

[11]	Kamata M, Tada Y. Dendritic cells and macrophages in the pathogenesis of psoriasis[J]. Front Immunol, 2022, 13: 941071.

[12]	Xiong DK, Shi X, Han MM, et al. The regulatory mechanism and potential application of IL-23 in autoimmune diseases[J]. Front Pharmacol, 2022, 13: 982238.

[13]	Tan Z, Lin ZJ, Wu LJ, et al. The macrophage IL-23/IL-17A pathway: a new neuro-immune mechanism in female mechanical pain[J]. Neurosci Bull, 2022, 38(4): 453-455.

[14]	Hawkes JE, Yan BY, Chan TC, et al. Discovery of the IL-23/IL-17 signaling pathway and the treatment of psoriasis[J]. J Immunol, 2018, 201(6): 1605-1613.

[15]	Coimbra S, Figueiredo A, Castro E, et al. The roles of cells and cytokines in the pathogenesis of psoriasis[J]. Int J Dermatol, 2012, 51(4): 389-395.

[16]	Song C, Yang C, Meng S, et al. Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23/Th17 cell axis[J]. J Ethnopharmacol, 2021, 281: 114571.

[17]	Meng S, Lin Z, Wang Y, et al. Psoriasis therapy by Chinese medicine and modern agents[J]. Chin Med, 2018, 13: 16.

[18]	Wei RL, Li ZR, Cao RD, et al. New analysis of Banxia Xiexin Decoction and its similar prescriptions in treatise on febrile diseases to explore the universality of the treatment and compatibility principle[J]. WJTCM, 2022, 8(4): 509-513.

[19]	Xu M, Deng J, Xu K, et al. In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine[J]. Theranostics, 2019, 9(9): 2475-2488.

[20]	Yao DN, Lu CJ, Wen ZH, et al. Comparison of PSORI-CM01 granules and Yinxieling Tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial[J]. Ann Palliat Med, 2021, 10(2): 2036-2047.

[21]	Xiang CL. Integrated Network Pharmacology and Metabolomics to Explain Possible Mechanisms of Gu-Ben-Qu-Shi-Hua-Yu Decoction for Treating Psoriasis[D]. Guangzhou University of Chinese Medicine, 2021.

[22]	Zhao M, Yao L, Zhang X, et al. Global identification of the cellular targets for a multi-molecule system by a photochemically-induced coupling reaction[J]. Chem Commun (Camb), 2021, 57(28): 3449-3452.

[23]	Li T, Gao S, Han W, et al. Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis[J]. J Ethnopharmacol, 2022, 294: 115275.

[24]	Parab S, Doshi G. An update on emerging immunological targets and their inhibitors in the treatment of psoriasis[J]. Int Immunopharmacol, 2022, 113(Pt A): 109341.

[25]	Yang K, Oak ASW, Elewski BE. Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review[J]. Am J Clin Dermatol, 2021, 22(2): 173-192.

[26]	Yu K, Yu X, Cao S, et al. Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis[J]. Acta Pharm Sin B, 2021, 11(2): 505-519.

[27]	Chen Y, Li K, Jiao M, et al. Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy[J]. Acta Pharm Sin B, 2023, 13(2): 787-803.

[28]	Altenburg A, Augustin M, Zouboulis CC. Side effects of biologic therapies in psoriasis[J]. Hautarzt, 2018, 69(4): 290-297.

[29]	Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review[J]. JAMA, 2020, 323(19): 1945-1960.

[30]	Wang Y, Chen S, Du K, et al. Traditional herbal medicine: therapeutic potential in rheumatoid arthritis[J]. J Ethnopharmacol, 2021, 279: 114368.

[31]	Ma HD, Deng YR, Tian Z, et al. Traditional Chinese medicine and immune regulation[J]. Clin Rev Allergy Immunol, 2013, 44(3): 229-241.

[32]	Liu WB, Li S, Yu XL, et al. Research progress on Chinese medicine immunomodulatory intervention for chronic primary immune thrombocytopenia: targeting cellular immunity[J]. Chin J Integr Med, 2019, 25(7): 483-489.

[33]	Lu CJ, Yu JJ, Deng JW. Disease-syndrome combination clinical study of psoriasis: present status, advantages, and prospects[J]. Chin J Integr Med, 2012, 18(3): 166-171.

[34]	Herman A, Herman AP. Topically used herbal products for the treatment of psoriasis: mechanism of action, drug delivery, clinical studies[J]. Planta Med, 2016, 82(17): 1447-1455.

[35]	Dai YJ, Li YY, Zeng HM, et al. Effect of Yinxieling Decoction on PASI, TNF-α and IL-8 in patients with psoriasis vulgaris[J]. Asian Pac J Trop Med, 2014, 7(8): 668-670.

[36]	Uranishi H, Tetsuka T, Yamashita M, et al. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator [J]. J Biol Chem, 2001, 276(16): 13395-1401.

[37]	Han G, Li X, Wen CH, et al. FUS contributes to nerve injury-induced nociceptive hypersensitivity by activating NF-κB pathway in primary sensory neurons[J]. J Neurosci, 2023, 43(7): 1267-1278.

[38]	Zhang C, Han X, Yang L, et al. Circular RNA circPPM1F modulates M1 macrophage activation and pancreatic islet inflammation in type 1 diabetes mellitus[J]. Theranostics, 2020, 10(24): 10908-10924.

[39]	Morchikh M, Cribier A, Raffel R, et al. HEXIM1 and NEAT1 long non-coding RNA form a multi-subunit complex that regulates DNA-mediated innate immune response[J]. Mol Cell, 2017, 67(3): 387-399.e5.

[40]	Yang L, Gal J, Chen J, et al. Self-assembled FUS binds active chromatin and regulates gene transcription[J]. Proc Natl Acad Sci U S A, 2014, 111(50): 17809-17814.

[41]	Xue YC, Ng CS, Mohamud Y, et al. FUS/TLS suppresses enterovirus replication and promotes antiviral innate immune responses[J]. J Virol, 2021, 95(12): e00304-e00321.

[42]	Wang D, Wang X, Tong W, et al. Umbelliferone alleviates lipopolysaccharide-induced inflammatory responses in acute lung injury by down-regulating TLR4/MyD88/NF-κB signaling[J]. Inflammation, 2019, 42(2): 440-448.

[43]	Zhang RX, Li MX, Jia ZP. Rehmannia glutinosa: review of botany, chemistry and pharmacology[J]. J Ethnopharmacol, 2008, 117(2): 199-214.

[44]	Li J, Yu H, Yang C, et al. Therapeutic potential and molecular mechanisms of echinacoside in neurodegenerative diseases[J]. Front Pharmacol, 2022, 13: 841110.

[45]	Calixto-Campos C, Carvalho TT, Hohmann MS, et al. Vanillic acid inhibits inflammatory pain by inhibiting neutrophil recruitment, oxidative stress, cytokine production, and NF-κB activation in Mice[J]. J Nat Prod, 2015, 78(8): 1799-1808.

[46]	Liu Z, Peng Y, Ma P, et al. An integrated strategy for anti-inflammatory quality markers screening of traditional Chinese herbal medicine Mume Fructus based on phytochemical analysis and anti-colitis activity[J]. Phytomedicine, 2022, 99: 154002.